Trial · NCT03619902
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Imsidolimab | 1 | 8 | 1 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Imsidolimab | 1 | 8 | 3 |
| other | Blood folate decreased | Investigations | Imsidolimab | 1 | 8 | 1 |
| other | Blood glucose increased | Investigations | Imsidolimab | 1 | 8 | 1 |
| other | C-reactive protein increased | Investigations | Imsidolimab | 1 | 8 | 1 |
| other | White blood cell count increased | Investigations | Imsidolimab | 1 | 8 | 1 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Imsidolimab | 2 | 8 | 2 |
| other | Psoriasis | Skin and subcutaneous tissue disorders | Imsidolimab | 1 | 8 | 1 |
| other | Skin haemorrhage | Skin and subcutaneous tissue disorders | Imsidolimab | 1 | 8 | 1 |
| other | Mitral valve prolapse | Cardiac disorders | Imsidolimab | 1 | 8 | 1 |
| other | Myxomatous mitral valve degeneration | Cardiac disorders | Imsidolimab | 1 | 8 | 1 |
| other | Peripheral swelling | General disorders | Imsidolimab | 1 | 8 | 1 |
| other | Swelling face | General disorders | Imsidolimab | 1 | 8 | 1 |
| other | Humerus fracture | Injury, poisoning and procedural complications | Imsidolimab | 1 | 8 | 1 |
| other | Hypokalemia | Metabolism and nutrition disorders | Imsidolimab | 1 | 8 | 1 |
| other | Presyncope | Nervous system disorders | Imsidolimab | 1 | 8 | 1 |
| other | Acute kidney injury | Renal and urinary disorders | Imsidolimab | 1 | 8 | 1 |
| other | Vaginal haemorrhage | Reproductive system and breast disorders | Imsidolimab | 1 | 8 | 1 |
| other | Hypertension | Vascular disorders | Imsidolimab | 1 | 8 | 1 |
| serious | COVID-19 | Infections and infestations | Imsidolimab | 1 | 8 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03619902/events